Buscar

Una contribución de Jeff Lee del curso de formación para facilitadores ISSUP INEP Plus.

Un profesional especializado en tratamiento para trastornos por consumo de sustancias puede tener la capacidad de ser un proveedor integral de atención...

The UNODC and WHO report Treatment and care for people with drug use disorders in contact with the criminal justice system: Alternatives to conviction or punishment examines how health-centred, evidence-based responses can be integrated...

This multicentre randomised controlled study evaluated a 3-year intersectoral intervention designed to reduce alcohol, tobacco, and cannabis use among adolescents in a tri-border region of Brazil, Argentina, and Paraguay. The intervention...

ISSUP Tanzania presents its webinar titled 'Healthy Holiday Choices: Substance Prevention for Youth'.

La inteligencia artificial (IA) está transformando la forma en que entendemos y gestionamos los trastornos por consumo de sustancias (SUDs). Las siguientes lecturas seleccionadas destacan los desarrollos actuales, aplicaciones prácticas y...

The article explores how artificial intelligence (AI) is currently used — and could be used — in the field of addiction research and treatment. The authors note that AI (machine learning, data mining, predictive analytics) offers...

 

AGENDA

2025 FDA Perspective: Generative Artificial Intelligence-Enabled (GenAI) Digital Mental Health Medical Devices

FDA Perspective: Regulatory Considerations for Digital Mental Health Therapeutics

Topic 1: Large Language Models in...

Introduction

Addiction medicine is becoming more of an issue as addiction-related problems continue to plague people all over the globe, resulting in serious health consequences. Addiction has become increasingly prevalent in recent years...

Purpose of the Review:

Psychotherapy remains a fundamental component of mental health treatment, yet it encounters significant barriers to accessibility and efficacy. The integration of digital therapies, encompassing e-Health, m-Health...

Addictive substances are prevalent world-wide, and their use presents a substantial and persistent public health problem. A wide range of digital interventions to decrease use and negative consequences thereof have been explored, differing...

Objectives: This study systematically reviewed research on the utilization of chatbot-related technologies for the prevention, assessment, and treatment of various substance uses, including alcohol, nicotine, and other drugs.

Methods: Foll...

The article reports on an NIH-supported clinical trial showing that an artificial intelligence (AI)–based screening tool for opioid use disorder (OUD) can improve hospital outcomes without reducing quality of care. Embedded in the...

Panel Presented at Indonesia 2025 on the 18th of September 2025

Moderator: Kristiana Siste

Presentations:

Narendra Narotama: Quality Matters: Transforming the Future of Drug Use Disorder Treatment 

Annete Dale-Perera: Supporting...

Panel Presented at Indonesia 2025 on the 17th of September 2025

Moderator: Imelda Indriyani

Presentations:

Mirza Hapsari Massarapa: Reducing Drug-Related Crime: A Comprehensive Approach from the Indonesian Directorate General of...

Panel Presented at Indonesia 2025 on the 17th of September 2025

Moderator: Goodman Sibeko

Presentations:

Ma Veronica Felipe: International Consortium of Universities for Drug Demand Reduction

Joanna Travis-Roberts: Global Opportunities...

The issue of drug (NAPZA) abuse at the global, regional, and national levels remains a serious public health issue, with widespread impacts on social, economic, and security domains. Based on the 2023 National Survey on Drug Abuse conducted by BNN, BRIN, and BPS, the prevalence rate of drug abuse in Indonesia among individuals aged 15–64 years was1.73%, equivalent to approximately 3.33 million people. Furthermore, the prevalence rate of drug use was 2.20%, or approximately 4.24 million people.

Panel Presented at Indonesia 2025 on the 17th of September 2025

Moderator: Vivi Syarif

Presentations:

Erik Van der Veen: From Evidence to Action: Building Partnerships to Strengthen the Drug Demand Reduction Strategy

Bina Ampera Bukit:...

The 2025 Global Adderall Shortage: Clinical Impact, Public Health Risks, and Implications for Substance Use Professionals

Author: Benjamin Zohar, NCACIP – Nationally Certified Advanced Addiction Intervention Professional, Founder of Interv...